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EDITORIAL  COMMENT
Introduction
Chronic pelvic pain is often defined as constant or
intermittent cyclic or acyclic pelvic pain that persists
for 6 months or more,1 while dysmenorrhea, deep
dyspareunia, and intermenstrual pain constitute its
main symptom complex, which is frequently
investigated by laparoscopy. Chronic pelvic pain has
high prevalence rates between 14% and 24%.2 Due to
its often bothersome effect, it can have a profound
impact on a woman’s personal health and quality of
life, including an economic impact through loss of
working hours. Treatment of chronic pelvic pain is
sometimes unsuccessful, and hysterectomy often
becomes the final resort.3 Therefore, a conservative
surgery, if shown to be effective, would represent a
major improvement in its management.
The presence of nerve plexuses and ganglia in the
uterosacral ligaments has been known for over a
century,4 and ablation of nerve plexuses and ganglions
from the uterus has been performed for many years
through abdominal or vaginal routes, and the nearest
laparoscopic route, so-called laparoscopic uterosacral
nerve ablation (LUNA). There are widespread
variations in the LUNA technique without reliable
evidence of effectiveness.5 Fortunately, some recent
reports of randomized controlled studies have clarified
some roles of LUNA in the control of pelvic pain.6,7
Variations in LUNA Methods
LUNA originally involves the transection of the
uterosacral ligaments as close to their insertion into
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the cervix as possible. The procedure interrupts pelvic
afferent sensory nerve fibers of the Lee-Frankenkauser
nerve plexus. In a 1955 study of Doyle et al,
vaginal transection of the nerves was effective for
dysmenorrhea; however, recent anatomical studies
by Fujii et al9 showed that the majority of uterosacral
nerve fiber bundles were found at a distance of 6.5–
33 mm and at a depth of 3–5 mm distal to the site of
attachment of the uterosacral ligaments to the cervix.
Wide variations in the practice of LUNA have been
shown by comparing the UK group with the rest of
Europe. The latter were more likely to completely
transect the uterosacral ligaments (56% vs 36%) at a
distance 2 cm or more from its cervical insertion (50%
vs 21%) than the UK group. Even the tools for
ablation varied between these 2 groups, i.e. laser
cutting (3% vs 32%), electrodiathermy (78% vs 75%),
scissors cutting (22% vs 15%), and harmonic scalpel
for cutting (8% vs 11%).9 There is widespread clinical
uncertainty in the techniques, with insufficient
evidence of effectiveness, thereby making it both
harder to determine the optimal time, depth, and site
of LUNA procedures, and the opinions regarding its
use uncertain and variable.
Effectiveness of LUNA
A structured survey was used to analyze gynecologists’
prior beliefs on the effectiveness for LUNA on pelvic
pain by both numeric response (on a l0-point visual
analog scale [VAS]) and by responses to a questionnaire.
The most widely held “prior belief” was that LUNA
would have small beneficial effect on pain.11
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LUNA for cyclic and noncyclic pelvic pain
without endometriosis
Both uncontrolled and randomized double-blind
studies had claimed support for LUNA with either
complete relief or substantial reduction in menstrual
pain in the majority of patients.6 Our preliminary
randomized study using LUNA as an adjuvant therapy
for treating patients with secondary dysmenorrhea
caused by uterine myoma also showed the effect of
LUNA in alleviating pain.12 Another randomized
study by Johnson et al6 included 123 patients with
chronic pelvic pain. In 56 patients with no laparoscopic
evidence of endometriosis, there was significant
reduction of dysmenorrheal, with a median change in
VAS from baseline –4.8 versus –0.8 (p = 0.039), or
42.1% versus 14.3% experiencing successful treatment
(p = 0.045). However, there is no evidence that
LUNA is beneficial for non-menstrual pelvic pain. In
a recent meta-analysis of 5 randomized trials, the
authors have approached a consensus on the
effectiveness of LUNA for menstrual pain. Similar
findings were reported by 4 other randomized
trials.13,14
LUNA for secondary dysmenorrhea with
endometriosis
In a randomized trial of 180 patients with symptomatic
endometriosis, the addition of LUNA to conservative
laparoscopic surgery for endometriosis did not reduce
the medium- or long-term frequency and severity of
recurrent dysmenorrheal.7 Another randomized study
of 67 patients with chronic pelvic pain and laparoscopic
evidence of endometriosis found no significant
difference in pain outcome.6
LUNA for other reasons
Vercellini et al’s7 randomized study showed that
LUNA had no additional effect for improvements
in health-related quality of life, psychiatric profile,
and sexual satisfaction. Also, another double-blind
randomized study of LUNA by Johnson et al6
revealed no beneficial effect for dyspareunia and
dyschezia.
Comparisons between LUNA and presacral
neurectomy (PSN) or laparoscopic PSN (LPSN)
In a randomized study, the comparison between
laparoscopic presacral neurectomy (LPSN) and LUNA
for control of primary dysmenorrhea showed
effectiveness of 87.9% and 82.9%, respectively, at the
3-month postoperative follow-up, whereas, long-
term LPSN was shown to be more effective than
LUNA (81.8% vs 51.4 % at the 12-month visit).14
Another study showed that the efficacy of LUNA
declined from 72% in the first year to 39% in the
fourth year.13 However, only PSN but not LUNA
was beneficial for alleviating secondary dysmenorrhea
associated with endometriosis in some randomized
studies.6
Adverse Events
The adverse events of PSN were significantly more
common than those of LUNA. In general, LUNA is
extremely safe except for a few complications reported
in the literature, which might not be specifically
associated with LUNA.5
Juang et al Study
We read with great interest the article by Juang et al.15
On the results of this 12-month follow-up study of
LUNA for treating primary deep dyspareunia, the
satisfactory rates at 3 and 12 months were 66.7% and
50%, respectively. To my knowledge, there has been
no similar report specifically on the treatment of
primary deep dyspareunia by the LUNA procedure.
This procedure was originally designed for treatment
of dysmenorrhea associated with endometriosis.6
Nevertheless, Vercellini et al7 found no significant
advantage on sexual satisfaction by the LUNA
procedure.
Deep dyspareunia is very complicated in its
pathogenesis, which includes both physical and
psychiatric/psychologic aspects; hence a verified
system comprising clarified definitions and criteria in
the assessment of satisfaction or improvement is
mandatory, referring to, e.g. the suitability and
rationale of using the Hospital Anxiety and Depression
Scale (HADS) and the “revised” scale of the
Sabbatsberg Sexual Rating Scale (rSSRS) for
evaluating dyspareunia. Another comment on Juang
et al’s report is the lack of group evaluators, including
personnel who are qualified for appraising a sexologic
and psychiatric/psychologic questionnaire to give
more informed insight. There is a need for elementary
descriptions in this article of the operative depth,
width, and distance to the cervical insertion of the
uterosacral ligaments; as well as the preoperative and
postoperative pain status, such as the presence of
menstrual or non-menstrual pain. Finally, the rationale
of LUNA procedures in treating primary deep
dyspareunia requires explanation in Juang et al’s
article.
LUNA and chronic pelvic pain
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Summary
Chronic pelvic pain is a complicated syndrome
comprised of different types of pain, including
dysmenorrhea, deep dyspareunia, and intermenstrual
pain, which can make interpretation difficult. Therefore,
investigation of this complex syndrome requires very
careful consideration.
Accumulating data from several randomized studies,
we have now come to realize that LUNA can be an
option in a few circumstances, especially for control of
menstrual pain without endometriosis; however, its
effectiveness may not extend to other indications, such
as alleviating secondary dysmenorrhea associated with
endometriosis (although it could, however, be reached
by presacral neurectomy). Juang et al’s article reports a
very preliminary experience in the treatment of primary
deep dyspareunia, presenting a promising perspective
yet without sufficient evidence on the management of
deep dyspareunia. A randomized controlled study with
an adequate number of patients is warranted.
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